Dose Escalation Study of TAB08 in Patients With Advanced Solid Neoplasms

NCT03006029 · clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
12
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Theramab LLC